Cranio maxillofacial surgery refers to a procedure for treatment of a severe injury to the cranial and facial bones. Surgery is usually performed by an oral and maxillofacial surgeon and may require an orthopedic trauma specialist, who focuses on caring for patients in critical condition.
Treatment of injured cranial and facial bones usually requires internal fixators such as plate and screw fixation systems, flap fixation devices, bone graft substitutes or others to fix the facial fracture. Car accidents are a common reason for cranio maxillofacial injuries and other trauma fractures, beside slips, falls and industrial accidents. The incidence rate of facial fractures is rising every year. Depending on the condition, one or more fixators are used to treat a single fracture.
North America, including the U.S. has the largest cranio maxillofacial implants market. Asia is the fastest growing cranio maxillofacial implants market. Some of the fastest growing markets for cranio maxillofacial implants devices are China, Japan and other countries in South East Asia and the Eastern Mediterranean.
Globally, the cranio maxillofacial implants market is witnessing significant growth due to increasing incidence of facial fractures and emergence of new procedural techniques and positive clinical outcome. In addition, increased healthcare expenditure and lack of substitutes are driving the cranio maxillofacial implants market. However, various factors such as high cost of surgery and lack of awareness are restraining the growth of cranio maxillofacial implants market. In addition, double surgery and absence of health insurance in the developing countries are restraining the cranio maxillofacial implants market.
Cranio maxillofacial implants are usually made of metals and its alloys, or of bioabsorbable materials. Titanium alloys are currently the most widely used, followed by alloys of stainless steel. Bioabsorbable materials, although new in the market, have gained much popularity. Various compounds, such as polyglycolides and polylactides, are being used to manufacture orthopedic implants, which can be absorbed by the body. No further surgery is required for the removal of such implants.
This report provides in-depth analysis and estimation of the cranio maxillofacial implants market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The cranio maxillofacial implants market is categorized on the basis of mode of location, composition, nature, product type and geography. Based on mode of location, the cranio maxillofacial implants market comprises internal fixators and external fixators. Based on composition, the market comprises of calcium ceramics, metals and alloys, polymers and biological materials. Based on nature, the cranio maxillofacial implants market comprises non-resorbable and resorbable implants.
In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). North America is further segmented into the U.S. and rest of North America. Similarly, Europe is further segmented into the U.K., Germany and France. Asia is further segmented into Japan and China. Some of the major players in the e-clinical solution software market are Johnson & Johnson Services, Inc., Stryker Corporation, Zimmer Holding, Inc., B. Braun Melsungen AG, CONMED and Medtronic, Inc. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote